Phytopharm plc Stock London S.E.
Stocks
GB0006869720
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 07-13 | Oil rises as Iran escalation keeps FTSE subdued | AN |
| 07-13 | Ixico notes ending of Huntington's disease programmes | AN |
| Market Cap | 16.35M 22.04M 19.1M 18.03M 30.68M 2.11B 30.9M 215M 82.96M 1.07B 82.8M 80.97M 3.41B | P/E 2026 * |
-5.36x | P/E 2027 * | -5.77x |
|---|---|---|---|---|---|
| Enterprise Value | 6.15M 8.3M 7.19M 6.78M 11.54M 795M 11.63M 81.01M 31.22M 403M 31.16M 30.47M 1.28B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 1.14x |
| Free-Float |
89.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Phytopharm plc
| Manager | Title | Age | Since |
|---|---|---|---|
Bram Goorden
CEO | Chief Executive Officer | 53 | 2024-08-18 |
Grant Nash
DFI | Director of Finance/CFO | 50 | 2019-08-20 |
Mark Austin
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Warne
CHM | Chairman | 51 | - |
Grant Nash
BRD | Director/Board Member | 50 | 2019-08-20 |
Katherine Rogers
BRD | Director/Board Member | 60 | 2022-01-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.56% | -5.82% | -2.45% | +9.99% | 45.48B | |
| +0.60% | -1.05% | +344.05% | +530.26% | 43.68B | |
| +1.52% | +2.43% | +42.77% | +24.68% | 43.09B | |
| +2.14% | +0.85% | +6.68% | +78.57% | 39.4B | |
| +0.34% | -4.94% | +9.34% | +40.23% | 31.91B | |
| +0.52% | -3.13% | - | - | 17.31B | |
| +0.96% | +0.50% | +19.63% | +112.07% | 16.4B | |
| +2.07% | -0.77% | +13.07% | +32.89% | 14.24B | |
| -1.98% | -3.24% | +78.44% | +30.75% | 13.28B | |
| Average | +0.64% | -2.97% | +63.94% | +107.43% | 29.42B | |
| Weighted average by Cap. | +0.91% | -3.26% | +76.25% | +128.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8M 10.78M 9.34M 8.82M 15.01M 1.03B 15.12M 105M 40.58M 524M 40.5M 39.61M 1.67B | 9M 12.13M 10.51M 9.92M 16.88M 1.16B 17.01M 118M 45.66M 590M 45.57M 44.56M 1.88B |
| Net income | -2.14M -2.89M -2.5M -2.36M -4.02M -277M -4.05M -28.21M -10.87M -140M -10.85M -10.61M -447M | -2.8M -3.78M -3.27M -3.09M -5.25M -362M -5.29M -36.87M -14.21M -184M -14.18M -13.87M -584M |
| Net Debt | -10.2M -13.75M -11.91M -11.24M -19.13M -1.32B -19.27M -134M -51.74M -669M -51.64M -50.5M -2.13B | -6.1M -8.22M -7.13M -6.72M -11.44M -788M -11.53M -80.3M -30.94M -400M -30.88M -30.2M -1.27B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
